Cargando…
Evaluation of the circulating level of fibroblast activation protein α for diagnosis of esophageal squamous cell carcinoma
To evaluate whether circulating fibroblast activation protein α (FAPα) could serve as a biomarker for the diagnosis of esophageal squamous cell carcinoma (ESCC), enzyme-linked immunosorbent assay (ELISA) was used to detect plasma FAPα in 556 participants including ESCC group, benign esophageal disea...
Autores principales: | Liao, Yuehua, Xing, Shan, Xu, Banglao, Liu, Wanli, Zhang, Ge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444725/ https://www.ncbi.nlm.nih.gov/pubmed/28415791 http://dx.doi.org/10.18632/oncotarget.16274 |
Ejemplares similares
-
Higher heat shock factor 1 expression in tumor stroma predicts poor prognosis in esophageal squamous cell carcinoma patients
por: Liao, Yuehua, et al.
Publicado: (2015) -
A synthetic urinary probe–coated nanoparticles sensitive to fibroblast activation protein α for solid tumor diagnosis
por: Feng, Xinwei, et al.
Publicado: (2017) -
Intracellular Fusobacterium nucleatum infection attenuates antitumor immunity in esophageal squamous cell carcinoma
por: Li, Yiqiu, et al.
Publicado: (2023) -
Fibroblast Activation Protein-α Expressing Fibroblasts Promote Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma
por: Li, Feng, et al.
Publicado: (2020) -
Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma – Mini Review
por: Shi, Yujing, et al.
Publicado: (2021)